Phase II trial of N-methylformamide in lung cancer.
Cody
R L
RL
Department of Internal Medicine, University of Michigan, Ann Arbor 48109-0504.
Seid
J E
JE
Natale
R B
RB
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D005559:Formamides / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000970:Antineoplastic Agents; D005559:Formamides; C002950:methylformamide